Contact us now for a free consultation with one of our HIFU experts!

call us today!
877-766-8400

Exciting news with FDA approval for HIFU!

.

INTRODUCTION AND OBJECTIVES

High Intensity Focused Ultrasound (HIFU) therapy offers significant theoretical advantages over conventional definitive treatments for localized prostate cancer with fewer side effects and reduced cost. Efficacy of HIFU, however, remains in question. The purpose of this study is to assess the outcomes of our modified HIFU patient selection protocol utilizing Multi-Parametric MRI (MP-MRI) imaging and PSA cutoff levels for the identification and improved management of localized prostate cancer patients treated with HIFU therapy.

METHODS

Retrospective 85 month pilot study of prospectively collected data on 67 HIFU patients previously identified with biopsy proven localized prostate cancer. Inclusion criteria: 1) localized lesions based on MP-MRI. 2) PSA levels ≤ 8.5 ng/ml. Outcome parameters: 1) Biochemical Disease Free Rate. 2) Need for definitive salvage therapy.

Treatment & Travel:

  • Where can I have the treatment done?
  • How do I schedule treatment?
  • Is the procedure covered by insurance or Medicare?
  • What information do you need from me prior to treatment?
Age/City/StateHighest PSAPre-HIFU Gleason scorePIRADS score
S.S.73 Earlton, FL9.42 ng/ml5+4=94 out of 5
W.K.73 Earlton, FL9.42 ng/ml5+4=94 out of 5
J.S.73 Earlton, FL9.42 ng/ml5+4=94 out of 5
E.W.73 Earlton, FL9.42 ng/ml5+4=94 out of 5
P.D.73 Earlton, FL9.42 ng/ml5+4=94 out of 5
F.M.73 Earlton, FL9.42 ng/ml5+4=94 out of 5
D.M.73 Earlton, FL9.42 ng/ml5+4=94 out of 5
W.A.73 Earlton, FL9.42 ng/ml5+4=94 out of 5
Call or Email us today for more information about HIFU* (with an Asterisk)! Our Niche Market at HCOA is treating Aggressive Prostate Cancer with predictable excellence!